Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP717708.RAuHKk-6jqt980cDSlR1gY5Y-9PZKDjsgAC7ZCH4Uclis130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP717708.RAuHKk-6jqt980cDSlR1gY5Y-9PZKDjsgAC7ZCH4Uclis130_assertion type Assertion NP717708.RAuHKk-6jqt980cDSlR1gY5Y-9PZKDjsgAC7ZCH4Uclis130_head.
- NP717708.RAuHKk-6jqt980cDSlR1gY5Y-9PZKDjsgAC7ZCH4Uclis130_assertion description "[However, RA patients homozygous for the IL6 -174 GG genotype had more severe endothelial dysfunction (flow-mediated endothelium-dependent vasodilatation-FMD%: 4.2 + or - 6.6) than those carrying the IL6 -174 GC (FMD%: 6.3 + or - 8.1) or IL6 -174 CC (FMD%: 6.0 + or - 3.3) genotypes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP717708.RAuHKk-6jqt980cDSlR1gY5Y-9PZKDjsgAC7ZCH4Uclis130_provenance.
- NP717708.RAuHKk-6jqt980cDSlR1gY5Y-9PZKDjsgAC7ZCH4Uclis130_assertion evidence source_evidence_literature NP717708.RAuHKk-6jqt980cDSlR1gY5Y-9PZKDjsgAC7ZCH4Uclis130_provenance.
- NP717708.RAuHKk-6jqt980cDSlR1gY5Y-9PZKDjsgAC7ZCH4Uclis130_assertion SIO_000772 20149313 NP717708.RAuHKk-6jqt980cDSlR1gY5Y-9PZKDjsgAC7ZCH4Uclis130_provenance.
- NP717708.RAuHKk-6jqt980cDSlR1gY5Y-9PZKDjsgAC7ZCH4Uclis130_assertion wasDerivedFrom befree-20140225 NP717708.RAuHKk-6jqt980cDSlR1gY5Y-9PZKDjsgAC7ZCH4Uclis130_provenance.
- NP717708.RAuHKk-6jqt980cDSlR1gY5Y-9PZKDjsgAC7ZCH4Uclis130_assertion wasGeneratedBy ECO_0000203 NP717708.RAuHKk-6jqt980cDSlR1gY5Y-9PZKDjsgAC7ZCH4Uclis130_provenance.